Navigation Links
St. Jude identifies genomic causes of a certain type of leukemia relapse
Date:11/27/2008

and be responsible for relapse."

According to the researchers, the relapse-related genetic changes commonly disrupted the machinery by which white blood cells called B cells mature and proliferate. Importantly, the relapse-related genetic changes only infrequently involved genes directly regulating the responsiveness to anti-cancer drugs.

The analysis also indicated that in most cases, the cancer cells responsible for relapse were related to those that originally gave rise to the cancer. Those relapse cells were present at low levels at diagnosis, the scientists' analysis indicated. However, in a few cases, the relapse cells evolved from genetically distinct cells, indicating that the relapsed leukemia was actually an entirely new cancer.

"The key finding in our work is that in the majority of cases, relapse is arising from a cell already present at the time of diagnosis," said James Downing, M.D., St. Jude Scientific Director, chair of the Department of Pathology and the paper's senior author. "That cell is selected for during treatment and then subsequently emerges as basis for relapse."

"The second key point is that we have found a large number of new genetic alterations that had not been previously identified as new targets of copy number changes at the time of relapse," Mullighan added.

Mullighan emphasized that the findings do not mean immediate treatments for ALL relapse. "But, this is a very important starting point because we have identified several key pathways that are the most common targets of new genetic changes at the time of relapse," he said.

Identification of these relapse pathways will lead to understanding of the biological machinery of relapse, and ultimately to drugs that target that machinery. Such studies of the relapse machinery are now underway at St. Jude.

In other further studies, the researchers are also looking for other relapse-related genetic alterations besides copy num
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. LSUHSC research identifies key contributor to Alzheimers disease process
2. Pitt research identifies new target in brain for treating schizophrenia
3. Research identifies type of vaccine that holds promise in protecting against TB
4. Conaway Lab identifies novel mechanism for regulation of gene expression
5. HPV DNA test identifies cervical pre-cancerous disease in developing countries with 90% success rate
6. New method identifies meth hot spots
7. Study identifies changes to DNA in major depression and suicide
8. UCLA study identifies mechanism behind mind-body connection
9. International team identifies 21 new genetic risk factors for Crohns disease
10. Stowers Institutes Shilatifard Lab identifies new role for factor critical to transcription
11. Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...2009) Whitehead researchers have developed a new ... specific genes and proteins used by pathogens, ac...uman cell cultures genes are present in two copies...other. Gene inactivation by mutation is therefore ...the second copy usually remains active and takes o...
(Date:11/25/2009)...he California Institute of Technology (Caltech) ha...behavior in the fruit fly, Drosophila melanogaste...he relationship between the neurotransmitter dopam...ADHD), are described in the December issue of the ...ins only about 20,000 neurons and has long been co...
(Date:11/25/2009)...police officers and ambulance workers faced a terr...plex. They battled to save people from the collaps...ires and evacuated as many people as they could in...e. And making their jobs even harder was the probl...their relatives jammed mobile networks with calls ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Magic box for mission impossible 2Magic box for mission impossible 3Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 1Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 2Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 3Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 4Pamela Davis Announced as Recipient of ACFE Sentinel Award 51847 1Pamela Davis Announced as Recipient of ACFE Sentinel Award 51847 2Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL 28R 29 for Treatment of Advanced Breast Cancer 51845 1Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL 28R 29 for Treatment of Advanced Breast Cancer 51845 2Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL 28R 29 for Treatment of Advanced Breast Cancer 51845 3Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL 28R 29 for Treatment of Advanced Breast Cancer 51845 4Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL 28R 29 for Treatment of Advanced Breast Cancer 51845 5Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL 28R 29 for Treatment of Advanced Breast Cancer 51845 6
...A&M University and The University of Glasgow V...aturally occurring endogenous retroviruses are req... class of endogenous retroviruses, known as endoge...ovirus or enJSRVs, are critical during the early p...lop. , Retroviruses, such as human immunodeficie...
...ns Bloomberg School of Public Health, the Imperial...dia, in Lima, Peru, and other institutions have de...est. The test, called microscopic-observation drug... and cheaper to perform than current culture-based...2006, issue of the New England Journal of Medicine...
...devised a way to use a brief burst of electricity ...iny gold launch pad. The technique could someday b...mmand from a chip implanted in the body. The metho...quire the controlled release of extremely small qu...ibed Sept. 10 in a presentation by Peter C. Searso...
Other Biology News:Researchers discover that sheep need retroviruses for reproduction 2Faster, more accurate tuberculosis test developed 2Electric jolt triggers release of biomolecules, nanoparticles 2
(Date:11/30/2009)...S, Ohio, Nov. 30 The Ohio Capital ...nation,s first minority business early-stage capit...cember 3, is called "Transforming the Landscape of...age Capital Summit." It will feature several speak...s leaders and local minority entrepreneurs. ,,...
(Date:11/30/2009)...K, Nov. 30 The Michael ...today announced $1.5 million in total awards to si...sease-modifying therapies for Parkinson,s disease....es to Drug Discovery for Parkinson,s Disease prog...n, plc (NYSE: ELN ), a neuroscience-based biotec...
(Date:11/30/2009)...Nov. 30 Dr. Jessica Torrente, Assi...University Medical Center in Washington, D.C., dem...ic Gamma Imaging (BSGI) in clinical practice as an...ast cancer today at the annual meeting of the Radi...he purpose of the exhibit was to demonstrate how B...
(Date:11/30/2009)... PDS, a leader in providing smart and efficie...s Pajama Pathology®, evolutionizing work-from-...old standard’ software used by 8 of the Top ... ‘cost per slide’ basis. , ... 30, 2009 -- PDS has announced another evolution i...
Breaking Biology Technology:Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
...Simcere Pharmaceutical,Group (NYSE: SCR ), a lead...harmaceuticals and innovative anti-cancer pharmace...nced today that it intends to release its 2008,thi...before the market,opens in the United States. Simc...hief financial officer, Frank Zhigang Zhao, will h...
...20) -- Nektar Therapeutics (Nasdaq: NKTR ) today ...rom Nektar specific pulmonary delivery,assets, tec...n in cash., "This agreement will allow us to focu...tics using our PEGylation and conjugate chemistry-...sident and CEO Howard W. Robin.,"The transaction a...
... defects, bulk crystalline materials never achieve...hand, are so small there,s no room for defects. ("...er.) Yet while nanocrystalline materials may appro...most nanostructures have shown only a limited abil...y fail. Overcoming this limitation could lead to g...
Other Biology Technology:Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008 2Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 2Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 3Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 4Engineering nanoparticles for maximum strength 2Engineering nanoparticles for maximum strength 3Engineering nanoparticles for maximum strength 4
CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich
HP Guaranteed siRNA from QIAGEN
...or heterologous protein expression in the Drosoph...s derived from a primary culture of late stage (20...1). This versatile cell line grows rapidly at roo... suspension culture. S2 cells are available froze...
..., we in-troduced a new concept, namely production ...tional level at the T7 phage promoter, and (ii) at...id copy number, The main advantage of our dual-con...cally all of the outstanding features of the pET v...
Biology Products: